Audit, classify, and selectively forget stored memories. Covers memory enumeration and classification by type/age/access frequency, staleness detection for outdated references, fidelity checks using external anchors, a decision tree for selective withdrawal, tombstoned deaccession so removed content stays recoverable, counter-memory inoculation for failed strategies that would otherwise be re-derived, preemptive filtering rules for what should never become memories, and an audit trail so forgetting itself is reviewable. Use when memory has grown large and uncurated, when project state has shifted significantly since memories were written, when retrieval quality has degraded, or as periodic maintenance alongside manage-memory.
日本語の概要は準備中です。原文の説明を表示しています。
pjt222/agent-almanac☆ 372026年10月10日 更新
Purify water from wild sources using boiling, filtration, and chemical methods. Covers source assessment and priority ranking, sediment pre-filtering, method selection (boiling, chemical, UV, filter), altitude-adjusted boiling procedure, chemical treatment dosages, and safe storage practices. Use when needing drinking water in a wilderness setting, when available water sources are of unknown quality, in an emergency survival situation where dehydration is a risk, or when making water safe for cooking or wound cleaning.
日本語の概要は準備中です。原文の説明を表示しています。
pjt222/agent-almanac☆ 372026年10月10日 更新
Conduct rigorous cross-study meta-analysis of scRNA-seq data from ENCODE, integrating multiple single-cell transcriptomic datasets for a tissue/cell type. Use when the user wants to answer "what cell types exist in my tissue and what genes define them?" by combining scRNA-seq data across donors, labs, and platforms. Follows the Mawla et al. 2019 framework for assessing cross-study reproducibility, TIN-based quality filtering, and detection-limit-aware interpretation. Handles batch correction (Harmony/Seurat), dropout awareness, cross-contamination artifacts, and platform-specific biases. Use this skill for ANY scRNA-seq integration task, cross-dataset comparison, cell atlas construction, or reproducibility assessment involving ENCODE single-cell data.
日本語の概要は準備中です。原文の説明を表示しています。
ammawla/encode-toolkit☆ 212026年9月27日 更新
Calculates tumor mutational burden from WES/WGS/panel data with Friends of Cancer Research harmonization equations, per-assay calibration (FDA 10/Mb = 7.8 TSO500 = 8.4 OncomineTML), synonymous/indel/germline filtering, hypermutator tiering, blood TMB, and integration with HLA-LOH and neoantigen quality (Luksza 2017 fitness). Use when assessing ICI eligibility under tumor-specific cutoffs (McGrail 2021), comparing tissue vs bTMB, or auditing TMB-H reporting against ESMO 2024 and FDA pembrolizumab pan-tumor 2020.
日本語の概要は準備中です。原文の説明を表示しています。
lilinji/GeneTind-Life-Skills☆ 142026年8月21日 更新
Curação de dados acelerada por GPU para treinamento de LLM. Suporta texto/imagem/vídeo/áudio. Recursos incluem deduplicação fuzzy (16× mais rápida), filtragem de qualidade (30+ heurísticas), deduplicação semântica, redação de PII, detecção NSFW. Escala em GPUs com RAPIDS. Use para preparar datasets de treinamento de alta qualidade, limpar dados web ou deduplicar grandes corpora.
日本語の概要は準備中です。原文の説明を表示しています。
artubss/SKILLS-CLAUDE-CODE☆ 112026年5月17日 更新
MUST USE when the user provides a photo ZIP, photo folder, or still-image event material and asks for photo selection, album selection, highlights, digest photos, curation, or quality filtering. Use this instead of analyze-footage when the source is primarily still photos and the requested work is selecting images rather than editing or video planning.
日本語の概要は準備中です。原文の説明を表示しています。
mocchalera/video-os-v2☆ 52026年9月4日 更新
Calculates tumor mutational burden from WES/WGS/panel data with Friends of Cancer Research harmonization equations, per-assay calibration (FDA 10/Mb = 7.8 TSO500 = 8.4 OncomineTML), synonymous/indel/germline filtering, hypermutator tiering, blood TMB, and integration with HLA-LOH and neoantigen quality (Luksza 2017 fitness). Use when assessing ICI eligibility under tumor-specific cutoffs (McGrail 2021), comparing tissue vs bTMB, or auditing TMB-H reporting against ESMO 2024 and FDA pembrolizumab pan-tumor 2020.
日本語の概要は準備中です。原文の説明を表示しています。
peacezha/HPClaw☆ 32026年10月11日 更新